10q10k10q10k.net
Revolution Medicines, Inc.

Revolution Medicines, Inc.RVMDEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."

Top Holders

Holder% OwnedSharesChangeAs of
The Vanguard Group8.93%
14.6M
—2024-02-13
BlackRock, Inc.7.90%
13.0M
—2024-01-26
Wellington Management Group LLP6.83%
11.4M
▼ -2.26pp2024-11-08
BB Biotech AG3.10%
5.0M
—2024-02-13
Biotechnology Value Fund, L.P.1.90%
3.1M
▼ -2.50pp2024-02-14
Farallon Capital Partners, L.P.0.20%
329.6K
▼ -0.10pp2024-02-12
EcoR1 Capital, LLC0.10%
132.6K
▼ -6.70pp2024-02-14
The Column Group III, LP0.00%
76.2K
—2024-02-09

Insider Transactions

Net 90d: −$28.37M · buys $0 / sells $28.37M
Range:
Action:
Role:
InsiderRoleAction
2026-04-15GOLDSMITH MARK ASee RemarksOption exercise
23.2K
$4.09$95.1K
2026-04-15GOLDSMITH MARK ASee RemarksOption exercise
96.8K
$4.73$457.7K
2026-04-15GOLDSMITH MARK ASee RemarksSell (open market)
120.0K
$150.09$18.01M
2026-03-25Anthony ManciniSee RemarksOption exercise
37.5K
$33.62$1.26M
2026-03-25Anthony ManciniSee RemarksSell (open market)
1.8K
$93.22$167.8K
2026-03-25Anthony ManciniSee RemarksSell (open market)
3.1K
$94.16$294.5K
2026-03-25Anthony ManciniSee RemarksSell (open market)
21.1K
$95.49$2.01M
2026-03-25Anthony ManciniSee RemarksSell (open market)
11.0K
$96.43$1.06M
2026-03-25Anthony ManciniSee RemarksSell (open market)
400
$97.21$38.9K
2026-03-19Jeff CisliniGeneral CounselSell (open market)
1.2K
$97.44$113.3K
1–10 of 41
Page 1 / 5